Gammaherpesviruses and Lymphoproliferative Disorders
Tóm tắt
Epstein–Barr virus (EBV) and Kaposi's sarcoma herpesvirus (KSHV), formally designated human herpesvirus 4 (HHV-4) and 8 (HHV-8), respectively, are viruses that can cause a variety of cancers in humans. EBV is found in non-Hodgkin and Hodgkin lymphomas, as well as in lymphoproliferative disorders, which occur more commonly but not exclusively in individuals with immunodeficiency. EBV also causes nonlymphoid malignancies such as nasopharyngeal carcinoma. KSHV causes primary effusion lymphomas, multicentric Castleman's disease, and Kaposi's sarcoma. The frequency of lymphoid malignancies related to infection by one of these two herpesviruses is greatly increased in individuals with immunodeficiency, whether primary or acquired, for example, as a consequence of HIV infection and AIDS or in the case of therapeutic immunosuppression for organ transplantation. Our current understanding indicates that EBV and KSHV contribute to lymphomagenesis by affecting genomic stability and by subverting the cellular molecular signaling machinery and metabolism to avoid immune surveillance and enhance tumor cell growth and survival. Understanding the viral associations in specific lymphoproliferative disorders and the molecular mechanisms of viral oncogenesis will lead to better prevention, diagnosis, and treatment strategies for these diseases.
Từ khóa
Tài liệu tham khảo
Swerdlow SH, 2008, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
15. Kluin PM, Harris NL, Stein H, Leoncini L, Raphaël M, et al. 2008. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. See Ref. 14, pp. 265–66
21. Raphaël M, Said J, Borisch B, Cesarman E, Harris NL. 2008. Lymphomas associated with HIV infection. See Ref. 14, pp. 340–42
23. Stein H, Harris NL, Campo E. 2008. Plasmablastic lymphoma. See Ref. 14, pp. 256–57
24. Swerdlow SH, Webber SA, Chadburn A, Ferry JA. 2008. Post-transplant lymphoproliferative disorders. See Ref. 14, pp. 343–49
Nalesnik MA, 1988, Am. J. Pathol., 133, 173
31. Quintanilla-Martinez L, Kimura H, Jaffe ES. 2008. EBV-positive T-cell lymphoproliferative disorders of childhood. See Ref. 14, pp. 278–80
Filipovich AH, 1992, Cancer Res., 52, S5465
37. VanKrieken JH, Onciu M, Elenitoba-Johnson KSJ, Jaffe ES. 2008. Lymphoproliferative diseases associated with primary immune disorders. See Ref. 14, pp. 336–39
Kieff E, 2007, Fields Virology, 2603
Ballon G, 2006, Viral and Immunological Malignancies
Parravicini C, 1997, Am. J. Pathol., 151, 1517
Saini N, 2013, Case Rep. Oncol. Med., 2013, 292301
Carbone A, 1998, Blood, 91, 747
Sun SC, 2011, Curr. Top. Microbiol. Immunol., 349, 197